Medina-Munoz, Hugo C.
Kofman, Eric
Jagannatha, Pratibha http://orcid.org/0000-0003-0257-3139
Boyle, Evan A.
Yu, Tao http://orcid.org/0000-0002-7753-7741
Jones, Krysten L.
Mueller, Jasmine R.
Lykins, Grace D.
Doudna, Andrew T.
Park, Samuel S. http://orcid.org/0000-0002-9230-7661
Blue, Steven M. http://orcid.org/0000-0003-0279-6690
Ranzau, Brodie L. http://orcid.org/0000-0002-6170-7187
Kohli, Rahul M. http://orcid.org/0000-0002-7689-5678
Komor, Alexis C. http://orcid.org/0000-0001-5043-0998
Yeo, Gene W. http://orcid.org/0000-0002-0799-6037
Article History
Received: 3 October 2023
Accepted: 3 January 2024
First Online: 29 January 2024
Competing interests
: G.W.Y. is an SAB member of Jumpcode Genomics and a co-founder, member of the Board of Directors, on the SAB, equity holder, and paid consultant for Locanabio (until 31 December 2023) and Eclipse BioInnovations. G.W.Y. is a distinguished visiting professor at the National University of Singapore. G.W.Y.’s interests have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. A.C.K. is a member of the SAB of Pairwise Plants, is an equity holder for Pairwise Plants and Beam Therapeutics, and receives royalties from Pairwise Plants, Beam Therapeutics, and Editas Medicine via patents licensed from Harvard University. A.C.K.’s interests have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. Other authors declare no competing interests.